Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 194.99%6.04B | 127.34%2.26B | 43.32%1.45B | 105.53%8.3B | 314.46%4.24B | 101.80%2.05B | -0.22%995M | 1.01B | 23.09%4.04B | 1.02B |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | -133.15%-598M | 74.81%-909M | -518.37%-2.21B | -360.64%-2.7B | -36.88%-1.42B | 177.62%1.8B | -0.00%-3.61B | 528M | -31.46%1.04B | -1.04B |
Other operating expenses | -46.44%1.06B | 125.56%1.5B | 1.20%1.35B | 14.30%3.09B | 52.27%869.37M | 185.45%1.98B | -0.14%665M | --1.33B | 15.31%2.7B | --570.93M |
Total other operating income | 865.67%1.66B | -43.62%2.41B | 341.99%3.56B | 247.46%5.79B | 42.33%2.29B | 305.73%171.49M | -0.02%4.27B | --805M | 100.31%1.67B | --1.61B |
Operating profit | 2,609.45%6.64B | -31.11%3.17B | 657.35%3.66B | 266.47%10.99B | 174.45%5.66B | -32.95%245.14M | -0.04%4.6B | 483M | 69.72%3B | 2.06B |
Net non-operating interest income (expenses) | 90.25%-2M | 57.14%-9M | 20.00%-16M | 13.60%-75M | 42.01%-12.5M | 14.72%-20.51M | 1.87%-21M | -20M | -0.54%-86.81M | -21.56M |
Non-operating interest income | 21,571.83%70M | --66M | --17M | 152.52%6.37M | 1,985.55%5.49M | -63.87%323K | --0 | --0 | 150.05%2.52M | --263K |
Non-operating interest expense | 245.61%72M | 257.14%75M | 65.00%33M | -8.91%81.37M | -17.57%17.99M | -16.48%20.83M | -3.07%21M | --20M | 2.27%89.33M | --21.82M |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | 2,856.38%6.64B | -30.94%3.17B | 686.83%3.64B | 274.82%10.92B | 176.74%5.65B | -34.23%224.63M | -0.01%4.58B | 463M | 73.27%2.91B | 2.04B |
Income tax | 2,472.64%2.03B | -31.85%950M | 678.47%1.12B | 275.02%3.35B | 183.83%1.73B | -29.75%79.02M | -0.01%1.39B | 144M | 75.58%892.04M | 608.7M |
Net income | 3,063.95%4.61B | -30.57%2.21B | 690.28%2.52B | 274.73%7.57B | 173.72%3.92B | -36.44%145.61M | -0.01%3.19B | 319M | 72.28%2.02B | 1.43B |
Net income continuous operations | 3,064.64%4.61B | -30.54%2.22B | 690.60%2.52B | 274.73%7.57B | 173.72%3.92B | -36.44%145.61M | -0.01%3.19B | --319M | 72.28%2.02B | --1.43B |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 3,063.95%4.61B | -30.57%2.21B | 690.28%2.52B | 274.73%7.57B | 173.72%3.92B | -36.44%145.61M | -0.01%3.19B | 319M | 72.28%2.02B | 1.43B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 3,063.95%4.61B | -30.57%2.21B | 690.28%2.52B | 274.73%7.57B | 173.72%3.92B | -36.44%145.61M | -0.01%3.19B | 319M | 72.28%2.02B | 1.43B |
Gross dividend payment | ||||||||||
Basic earnings per share | 2,561.61%138.67 | -34.36%66.72 | 549.21%76.06 | 252.07%262.37 | 145.10%129.35 | -38.08%5.21 | -13.19%101.6414 | 11.7157 | 99.28%74.5231 | 52.7733 |
Diluted earnings per share | 2,584.92%129.95 | -38.59%62.42 | 554.30%71.1 | 256.22%243.93 | 148.04%120.45 | -38.00%4.84 | -6.46%101.6414 | 10.8666 | 83.11%68.4774 | 48.5614 |
Dividend per share | 0 | 12 | ||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |